Home/Services/Margin and cost improvement

Margin and Cost Improvement

Margin rarely fails in one place. It leaks through outdated payor contracts written years ago, referrals leaving for competitors, premium labor covering a scheduling problem, and drug spend nobody has re-tendered. Elevate works those levers together, because pulling one in isolation usually moves cost somewhere else.

Get in Touch
At a glance
Defined project or inside a retainer
Hospitals, health systems, physician networks
Remote nationwide, on site when necessary across LA and Orange County

Where Margin Is Usually Found

01

Payor contract renegotiation

Rate modelling and contract analysis that establishes what the organization is actually being paid against what comparable providers receive.

02

Referral leakage control

Tracing where referrals leave the network and what it costs, then closing the critical routes.

03

Premium labor reduction

Agency and overtime spend is examined as a scheduling and vacancy problem, not a line item to be cut.

04

Drug and implant costs

High-cost drug and implant spend brought down, alongside supply purchasing, where spend has outgrown volume.

05

Length of stay and throughput

Identify levers that move margin and capacity together. One half-day reduction in average length of stay has carried $1M in annualised EBITDA impact.

06

Payor mix analysis

Understanding which growth is worth having, since not all volume improves the bottom line.

How Margin Work Is Approached

Margin engagements begin with a quantified map, not a list of ideas. Each lever is sized, so the organization can see that one is worth eight figures and another is worth a rounding error, and sequence accordingly. Execution is where most margin programmes fail, so the work stays engaged through implementation and does not end at a recommendation deck. Progress is tracked against the P&L.

Usually delivered during a fractional or interim CFO engagement, since margin work requires decision-making power.
[ PRICING PLACEHOLDER — rates to be set after market research ]

Common Questions

How long before we see anything?
Contract renegotiation and drug spend move on their own timelines, which are largely external. Labor and throughput levers tend to show first because they are internal decisions.
Is this a cost-cutting exercise?
Not primarily. Several of the largest levers are revenue-side, including payor rates, referral leakage, and payor mix. Cost reduction is one part of a wider picture.
Do you work with our clinical leadership?
Length of stay and throughput cannot move without them, so yes. Those levers are operational as much as financial.
What if we have already done a cost programme?
That is not uncommon, and it is usually why the remaining margin is in the levers that need several functions moving together. Those are typically the ones isolated projects neglect.
Can you do this without a CFO engagement?
It can be scoped as a defined project, though it works better when whoever drives it also has the authority to act.
Evidence
$10M
Saved across a California market through contract renegotiation, leakage control, drug spend management, and avoidable ER visit reduction.
$1M+
Operational EBITDA gained at a physician network through premium labor reduction and clinic volume growth.

At a seven-hospital system, EBITDA improvement came from premium labor, length of stay, admissions, payor mix, and high-cost drug and implant spend worked together.

Get in touch

Partner with a Healthcare CFO

Direct access to seasoned financial leadership changes how healthcare executive teams operate. Contact Elevate to discuss your financial structure, operational bottleneck, or leadership needs.

Email info@elevatecfo.co
Based in Los Angeles, California
Elevate

Executive financial leadership for healthcare organizations: fractional and interim CFO, controller services, margin improvement and revenue cycle recovery.

Get in touch
info@elevatecfo.co
Los Angeles, California
Remote nationwide
© 2026 Elevate. All rights reserved.